Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Ming-Chao Tsai"'
Autor:
Ya‐Wen Hsiao, Fai‐Meng Sou, Jing‐Houng Wang, Yen‐Hao Chen, Ming‐Chao Tsai, Tsung‐Hui Hu, Chao‐Hung Hung, Chien‐Hung Chen, Yuan‐Hung Kuo
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 39, Iss 12, Pp 1233-1242 (2023)
Abstract Lenvatinib has been approved as one of the first‐line treatments for advanced hepatocellular carcinoma (HCC) due to its high treatment efficacy being non‐inferior to sorafenib. Previous studies have shown well‐controlled viremia contri
Externí odkaz:
https://doaj.org/article/b1252245566d40eeb3fd8e2ddd0e4a28
Autor:
Shih-Yu Yang, Tsung-Hui Hu, Yeh-Pin Chou, Yuan-Hung Kuo, Ming-Chao Tsai, Kuo-Chin Chang, Yi-Hao Yen, Po-Lin Tseng
Publikováno v:
Journal of Infection and Public Health, Vol 16, Iss 11, Pp 1852-1859 (2023)
Background: Prophylaxis antiviral therapy is recommended for patients with hepatitis B receiving chemotherapy but the ideal treatment duration after chemotherapy cessation needs more evidence for clarification. Aims: This study aimed to compare the r
Externí odkaz:
https://doaj.org/article/2b55cf6c24544b049bd644f0f356897a
Autor:
Wei-Ru Cho, Chih-Chi Wang, Mu-Jung Tsai, Chih-Che Lin, Yi-Hao Yen, Chien Hung Chen, Yuan-Hung Kuo, Chih-Chien Yao, Chao-Hung Hung, Pao-Yuan Huang, An-Che Liu, Ming-Chao Tsai
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 18 (2024)
Background: The risk of first recurrence of hepatocellular carcinoma (HCC) within years 5 to 10 after curative hepatectomy remains unknown. We aimed to assess the incidence and prognostic factors for very late recurrence among patients who achieved 5
Externí odkaz:
https://doaj.org/article/bbb17fa5e8f546c48bec8f2975145a64
Autor:
Yi-Hao Yen, Kwong-Ming Kee, Tsung-Hui Hu, Ming-Chao Tsai, Yuan-Hung Kuo, Wei-Feng Li, Yueh-Wei Liu, Chih-Chi Wang, Chih-Yun Lin
Publikováno v:
PLoS ONE, Vol 19, Iss 3, p e0290523 (2024)
BackgroundWhether the etiology of chronic liver disease (CLD) impacts the overall survival (OS) of patients with hepatocellular carcinoma (HCC) remains unclear. We aim to clarify this issue.Materials and methodsBetween 2011 and 2020, 3941 patients wh
Externí odkaz:
https://doaj.org/article/4f15f10721dc46be9b6cafc213ae8dd0
Autor:
Ya‐Chin Wang, Ming‐Chao Tsai, Yaw‐Sen Chen, Pei‐Min Hsieh, Chao‐Ming Hung, Hung‐Yu Lin, Yao‐Chun Hsu, Jen‐Hao Yeh, Pojen Hsiao, Yu‐Cheih Su, Ching‐Hou Ma, Chih‐Yuan Lee, Chih‐Che Lin, Chih‐Wen Shu, Yu‐Chan Li, Mei‐Hsing Tsai, James Yu Lin, Wei‐Hao Peng, Ming‐Lung Yu, Chih‐Wen Lin
Publikováno v:
Hepatology Communications, Vol 6, Iss 12, Pp 3563-3577 (2022)
Abstract Hepatocellular carcinoma (HCC) is a highly invasive malignancy. Recently, GATOR1 (Gap Activity TOward Rags 1) complexes have been shown to play an important role in regulating tumor growth. NPRL2 is a critical component of the GATOR1 complex
Externí odkaz:
https://doaj.org/article/570acea9db984957a14221e692b0d8b3
Autor:
Yu-Chieh Tsai, Fai-Meng Sou, Yueh-Wei Liu, Yi-Ju Wu, Chee-Chien Yong, Ding-Wei Chen, Pao-Yuan Huang, Wei-Ru Cho, Ching-Hui Chuang, Chang-Chun Hsiao, Tsung-Hui Hu, Ming-Chao Tsai
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The albumin–bilirubin (ALBI) grade has been validated as a significant prognostic predictor for hepatocellular carcinoma (HCC). However, there is little information about the ALBI grade in patients with non-B non-C HCC (NBNC-HCC
Externí odkaz:
https://doaj.org/article/3dcac68e63b24408b4555537b8b40c60
Autor:
Ming-Chao Tsai, Chih-Chi Wang, Wei-Chen Lee, Chih-Che Lin, Kuo-Chin Chang, Chien-Hung Chen, Chao-Hung Hung, Ming-Tsung Lin, Chang-Chun Hsiao, Chao-Long Chen, Rong-Nan Chien, Tsung-Hui Hu
Publikováno v:
Liver Cancer, Pp 1-16 (2021)
Background: It is unclear whether entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have different effects on hepatocellular carcinoma (HCC) recurrence and death in patients receiving curative hepatectomy for hepatitis B virus (HBV)-related HCC
Externí odkaz:
https://doaj.org/article/7136cae453d54b1e8f5bdfc9cd09fec0
Autor:
Chih-Chien Yao, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Kwong-Ming Kee, Tsung-Hui Hu, Ming-Chao Tsai, Yuan-Hung Kuo, Sheng-Nan Lu
Publikováno v:
Diagnostics, Vol 13, Iss 4, p 696 (2023)
Background: The role of des-γ-carboxy prothrombin (DCP) in patients undergoing radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) needs to be clarified. Materials and methods: 174 HCC patients that underwent RFA were enrolled. We calcu
Externí odkaz:
https://doaj.org/article/a9ba0b077c9445a6adeb04976b45ebea
Autor:
Ming-Tsung Lin, Kuo-Chin Chang, Yi-Hao Yen, Ming-Chao Tsai, Chien-Hung Chen, Jing-Houng Wang, Chang-Chun Hsiao, Yueh-Hsia Chiu, Tsung-Hui Hu
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 1, Pp 621-628 (2021)
Background/Purpose: Effective antiviral-therapy can reduce the risk of liver cirrhosis related hepatocellular carcinoma in patients with chronic hepatitis B and hepatitis C. Yet, the difference of hepatocellular carcinoma development in chronic hepat
Externí odkaz:
https://doaj.org/article/8663454c9c564cd7a1742faeaa2665f0
Autor:
Shih-Yu Yang, Chih-Chi Wang, Kuang-Den Chen, Yueh-Wei Liu, Chih-Che Lin, Ching-Hui Chuang, Yu-Chieh Tsai, Chih-Chien Yao, Yi-Hao Yen, Chang-Chun Hsiao, Tsung-Hui Hu, Ming-Chao Tsai
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Use of statins is associated with a reduced risk of hepatocellular carcinoma (HCC). However, the effect of statin use on HCC recurrence is unclear. This study aimed to evaluate the effect of statin use on recurrence after curative
Externí odkaz:
https://doaj.org/article/3c22d97a32e943d9bc2c3b4a86b9f980